For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240603:nRSC9165Qa&default-theme=true
RNS Number : 9165Q Oxford Nanopore Technologies plc 03 June 2024
03 June 2024
Oxford Nanopore Technologies plc (the "Company")
Issue of Equity and Total Voting Rights
The Company today announces in respect of the month ended 31 May 2024, the
issue of 237,946 ordinary shares of £0.0001 each ("Ordinary Shares"),
following the exercise of options granted under the Company's share option
plans and issuance of shares under certain of the Company's remuneration
schemes.
Such Ordinary Shares were also admitted to the Official List of the Financial
Conduct Authority ("FCA") and to trading on the London Stock Exchange's main
market for listed securities under the Company's block listing facility.
Following this issue, the Company has the ability to admit a further
19,492,334 Ordinary Shares under its block listing facility.
In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1,
the Company announces that as at 31 May 2024, the Company's issued share
capital consisted of 862,823,513 Ordinary Shares, one class A limited
anti-takeover ("LAT") share of £1.00, one class B LAT share of £1.00 and one
class C LAT share of £1.00. The Company did not hold any shares in treasury.
Only the Ordinary Shares are voting shares and each such Ordinary Share
carries one vote per Ordinary Share. Accordingly, the total number of voting
rights in the Company as at 31 May 2024 is 862,823,513. This figure may be
used by shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or a change
to their interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules. Enquiries:
Investors
ir@nanoporetech.com
Media
media@nanoporetech.com
OxfordNanoporeTechnologies@teneo.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TVREALKDEAXLEFA